Literature DB >> 12050244

Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management.

Warrick J Inder1, Penny J Hunt.   

Abstract

Patients undergoing surgical resection of pituitary adenomas are frequently given perioperative glucocorticoid therapy. There are no randomized controlled studies assessing the need for such steroids; however, several studies have documented changes in the hypothalamic-pituitary-adrenal (HPA) axis associated with pituitary surgery. Based on the evidence available, this article details recommendations for the perioperative management of glucocorticoid therapy in patients with pituitary tumors. For patients with proven ACTH deficiency preoperatively [usually based on response to a short ACTH 1-24 (Synacthen) test], 48 hours of supraphysiological glucocorticoid therapy should be administered perioperatively (e.g. hydrocortisone, 50 mg every 8 hours on day 0, 25 mg every 8 hours on day 1, and 25 mg at 0800 h on day 2). For patients with intact HPA function preoperatively, and in whom selective adenomectomy is possible, perioperative glucocorticoids are not necessary. Early postoperative assessment depends on daily clinical assessment of the patient and 0800 h plasma cortisol levels. Cortisol levels over 450 nM (16 microg/dl) reflect normal HPA function, and levels less than 100 nM (3.6 microg/dl) are consistent with ACTH deficiency. Cortisol levels between 100 and 250 nM (3.6-9 microg/dl) may be ACTH deficient and should receive morning hydrocortisone replacement until definitive HPA axis testing. Cortisol levels between 250 and 450 nM (9-16 microg/dl) are unlikely to be ACTH deficient but should receive additional steroids for stress until a definitive test is performed. For those requiring definitive testing, the insulin tolerance test, the overnight metyrapone test, or the glucagon stimulation test are appropriate and may be performed as early as d 7-10 or, if more convenient, wk 4-6. Following the guidelines suggested here should reduce the use of unnecessary glucocorticoids, while ensuring the safety of patients is not compromised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050244     DOI: 10.1210/jcem.87.6.8547

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.

Authors:  F R Pimentel-Filho; M E R Silva; K C Nogueira; K Berger; A Cukiert; B Liberman
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

2.  Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.

Authors:  Nicholas F Marko; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

3.  Socioeconomic Factors Affecting Discharge Status of Patients with Uncomplicated Transsphenoidal Adenohypophysectomy.

Authors:  Chelsea S Hamill; Jennifer A Villwock; Kevin J Sykes; Roukoz B Chamoun; D David Beahm
Journal:  J Neurol Surg B Skull Base       Date:  2018-02-26

4.  Pituitary apoplexy in an adrenocorticotropin-producing pituitary macroadenoma.

Authors:  Serap Baydur Sahin; S Cetinkalp; M Erdogan; U Cavdar; G Duygulu; F Saygili; C Yilmaz; A G Ozgen
Journal:  Endocrine       Date:  2010-07-14       Impact factor: 3.633

Review 5.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

6.  OUTCOME OF IMPLEMENTATION OF A MULTIDISCIPLINARY TEAM APPROACH TO THE CARE OF PATIENTS AFTER TRANSSPHENOIDAL SURGERY.

Authors:  Arthur S Carminucci; John C Ausiello; Gabrielle Page-Wilson; Michelle Lee; Laura Good; Jeffrey N Bruce; Pamela U Freda
Journal:  Endocr Pract       Date:  2015-10-05       Impact factor: 3.443

7.  Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease.

Authors:  Valentina Gasco; Alessandro Berton; Mirko Parasiliti Caprino; Ioannis Karamouzis; Mauro Maccario; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2014-12-09       Impact factor: 3.633

8.  Preoperative assessment of adult patients for intracranial surgery.

Authors:  Vanitha Sivanaser; Pirjo Manninen
Journal:  Anesthesiol Res Pract       Date:  2010-03-31

9.  Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.

Authors:  R Cozzi; G Lasio; A Cardia; G Felisati; M Montini; R Attanasio
Journal:  J Endocrinol Invest       Date:  2009-04-29       Impact factor: 4.256

10.  The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.

Authors:  Gabriel Zada; Amir Tirosh; Abel P Huang; Edward R Laws; Whitney W Woodmansee
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.